Public Hearing - October 4, 2017


Public Hearing on Synthetic Cathinones

Washington, DC

Wednesday, October 4, 2017

9:30 a.m. - 12:00 p.m.


Pursuant to Rule 3.4 of the Rules of Practice and Procedure of the United States Sentencing Commission, a public hearing is scheduled for Wednesday, October 4, 2017, from 9:30 a.m. – 12:00 p.m. (ET).

The public hearing will be held at the Thurgood Marshall Federal Judiciary Building, One Columbus Circle, N.E., Washington, DC in Suite 2-500 (South Lobby). 

The purpose of the public hearing is for the Commission to receive testimony from experts on synthetic cathinones, including their chemical structure, pharmacological effects, trafficking patterns, and community impact.

To receive updates on future events and other Commission activities, visit us on Twitter or subscribe to our e-mail listserve in the website footer below. For questions regarding this notice, e-mail our Public Affairs Office at or call us at (202) 502‐4500.

Panel I
Pharmacological Effects
9:30 a.m. – 10:15 a.m.

Cassandra Prioleau, Ph. D.
Drug Science Specialist
Drug and Chemical Evaluation Section
Office of Diversion Control
Drug Enforcement Administration

Michael Gatch, Ph.D.
Associate Professor – Biomedical Sciences
University of North Texas

Travis J. Worst, Ph.D.
Instructor of Forensic Science
Department of Chemistry
Bowling Green State University

Panel II
Medical Community and Treatment Provider Observations
10:15 a.m. – 10:50 a.m.

Heather A. Borek, M.D.
Assistant Professor of Emergency Medicine
Associate Fellowship Director for Medical Toxicology
University of Virginia School of Medicine

Christopher P. Holstege, M.D.
Professor of Emergency Medicine and Pediatrics
Chief, Division of Medical Toxicology
Medical Director, Blue Ridge Poison Control Center
University of Virginia School of Medicine

Darryl Inaba, PharmD., CADC-III, CATC-V
Director of Clinical and Behavioral Health Services
Addictions Recovery Center
Director of Research and Education
CNS Productions, Inc.

10:50 a.m. – 11:00 a.m.

Panel III
Chemical Structure
11:00 a.m. – 11:30 a.m.

Terrence L. Boos, Ph.D.
Section Chief, Drug and Chemical Evaluation Section
Diversion Control Division
Drug Enforcement Administration

Professor Gregory Dudley, Ph.D.
Eberly Family Distinguished Professor and Department Chair
Department of Chemistry
West Virginia University

Panel IV
Trafficking Patterns and Law Enforcement Issues
11:30 a.m. – 
12:00 p.m.

Neil D. Doherty
Associate Deputy Assistant Administrator
Office of Diversion Control
Drug Enforcement Administration

12:00 p.m.